MedTrace Logo

Physiologic Interactions Between the Adrenal- and the Parathyroid Glands

NCT02572960 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2018-08-15

No results posted yet for this study

Summary

To investigate possible physiologic interactions between the adrenal- and the parathyroid glands in patients with secondary hyperparathyroidism.

Conditions

Interventions

DRUG

Valsartan

2 weeks of Valsartan 80 mg per day

DRUG

Placebo Valsartan

2 weeks of Placebo Valsartan, one tablet per day. Placebo tablets are identical in regards to size and appearance to the experimental intervention tablet.

DIETARY_SUPPLEMENT

Cholecalciferol

12 weeks of daily cholecalciferol treatment, 70 microgram per day

DIETARY_SUPPLEMENT

Placebo cholecalciferol

12 weeks of daily Placebo cholecalciferol treatment. Placebo tablets are identical in regards to size and appearance to the experimental intervention tablet.

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Lars Rejnmark, Professor · Department of Endocrinology and Internal medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02572960 on ClinicalTrials.gov